Friday 6 November 2026 Export GILD’s income statement to Excel — free account

Gilead Sciences, Inc.

GILD Healthcare Drug Manufacturers General

Gilead Sciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $29.4 billion, up 2.40% from fiscal 2024.

Revenue: +6.83%
EPS: −20.5%
Free cash flow: +21.1%
Total debt: +5.17%

Quarter to September 2026, against a year earlier

166.96 0.61 −0.36%

Follow GILD

Alert me

Market cap: $207.8B
P/E: 0.0×
Fwd P/E: −41.3×
Dividend yield: 1.95%
F-score: 8/9
Altman Z: 4.03
Beneish M: −2.45
Dividend safety: 77/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Sep '26	Jun '26	Mar '26	Dec '25	Older periods
Piotroski F-Score Full definition →	5	5	9	8	+8 more TTM periods Free account
ROE Full definition →	(22.45%)	(20.68%)	43.36%	40.66%
ROA Full definition →	(7.03%)	(6.17%)	16.35%	14.42%
ROIC Full definition →	(4.51%)	(4.48%)	17.07%	15.69%
Return on Tangible Assets Full definition →	(39.37%)	(36.99%)	62.26%	70.13%
Average Days of Receivables Full definition →	58.98	60.58	58.19	60.91
Free Cash Flow per Share Full definition →	11.10	10.41	8.24	7.60
Free Cash Flow Full definition →	13,780.00	12,943.00	10,230.00	9,456.00
Capital Expenditures Full definition →	(699.00)	(609.00)	(576.00)	(563.00)
Other line items
Cash ROIC Full definition →	30.20%	31.44%	19.21%	17.13%
Accounts Receivable Turnover Full definition →	6.14	6.19	6.51	6.31
Accounts Payable Turnover Full definition →	7.14	9.90	8.88	8.05
Inventory Turnover Full definition →	2.00	3.29	3.34	3.58
Average Days of Payables Full definition →	54.82	39.57	38.35	41.86
Days of Inventory on Hand Full definition →	259.65	114.66	113.80	103.87
Tax Rate Full definition →	0.52	0.66	(0.14)	(0.13)
Research and Development Expense of Revenue Full definition →	20.42%	19.91%	19.48%	19.70%
Selling, General and Administrative Expense of Revenue Full definition →	21.97%	21.42%	20.07%	19.61%
Share Based Compensation of Revenue Full definition →	2.95%	2.98%	3.04%	3.04%
Interest Coverage Full definition →	(2.34)	(2.51)	10.33	9.79
Operating CF/Net income Full definition →	(3.75)	(4.18)	1.17	1.18
Depreciation/Fixed assets Full definition →	0.47	0.47	0.49	0.49
Capex/Depreciation Full definition →	(0.25)	(0.22)	(0.21)	(0.20)
Revenue per Share Full definition →	24.95	24.50	23.94	23.67
Operating CF per Share Full definition →	11.66	10.90	8.70	8.05
Capex per Share Full definition →	(0.56)	(0.49)	(0.46)	(0.45)
Capex to Sales Full definition →	0.02	0.02	0.02	0.02

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026

Stockrow Weekly